-+ 0.00%
-+ 0.00%
-+ 0.00%

IMMUNITYBIO ANNOUNCES APPROVAL IN MACAU SAR, CHINA FOR ANKTIVA® IN BCG-UNRESPONSIVE NMIBC WITH CIS ± PAPILLARY TUMORS

Reuters·03/20/2026 17:08:14

Please log in to view news